Liangming Liu Selected Research

Oligomycins

1/2017	HIF-1α regulates Cx40-dependent vasodilatation following hemorrhagic shock in rats.
11/2008	regulatory effects of hypoxia-inducible factor 1alpha on vascular reactivity and its mechanisms following hemorrhagic shock in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liangming Liu Research Topics

Disease

49	Hemorrhagic Shock 01/2022 - 02/2002
26	Shock 01/2022 - 06/2005
19	Hypoxia (Hypoxemia) 11/2021 - 01/2008
15	Hemorrhage 01/2021 - 02/2002
13	Sepsis (Septicemia) 01/2022 - 12/2015
12	Wounds and Injuries (Trauma) 01/2021 - 02/2002
9	Septic Shock (Toxic Shock Syndrome) 01/2021 - 07/2011
3	Multiple Organ Failure (MODS) 12/2015 - 02/2011
3	Hypotension (Low Blood Pressure) 05/2015 - 01/2011
2	Acidosis 01/2022 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 01/2019
2	Ischemia 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2018 - 01/2016
2	Reperfusion Injury 11/2016 - 10/2013
2	Hyponatremia 01/2016 - 05/2015
1	Chemical and Drug Induced Liver Injury 08/2021
1	Liver Diseases (Liver Disease) 08/2021
1	Myocardial Infarction 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020

Drug/Important Bio-Agent (IBA)

15	rho-Associated KinasesIBA 10/2017 - 06/2005
13	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 06/2005
13	CalciumIBA 05/2015 - 06/2005
11	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2002
10	Oxygen (Dioxygen)IBA 01/2021 - 03/2012
9	Arginine Vasopressin (Argipressin)IBA 10/2017 - 12/2006
8	LipopolysaccharidesIBA 01/2021 - 05/2015
8	Protein Kinase CIBA 10/2017 - 06/2006
6	Connexin 43 (Connexin43)IBA 01/2019 - 01/2009
6	Myosin Light Chains (Myosin Essential Light Chain)IBA 04/2014 - 01/2008
5	Ringer's LactateIBA 01/2021 - 01/2012
4	Mitochondrial Permeability Transition PoreIBA 11/2021 - 05/2015
4	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2015
4	Angiotensin IIIBA 01/2019 - 06/2006
4	ConnexinsIBA 01/2018 - 01/2009
4	Myosin-Light-Chain PhosphataseIBA 06/2011 - 01/2008
3	Phosphotransferases (Kinase)IBA 11/2021 - 02/2011
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2021 - 05/2015
3	SolutionsIBA 01/2021 - 03/2012
3	4-phenylbutyric acid (Buphenyl)FDA Link 01/2021 - 01/2016
3	Vasopressins (Vasopressin)IBA 10/2017 - 01/2016
3	Platelet-Derived Growth FactorIBA 11/2014 - 06/2011
3	Protein Kinases (Protein Kinase)IBA 04/2014 - 01/2010
2	AcidsIBA 01/2022 - 01/2009
2	Dynamins (Dynamin)IBA 11/2021 - 01/2020
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 05/2015
2	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 01/2021 - 10/2020
2	Starch (Cornstarch)IBA 01/2020 - 01/2012
2	Tight Junction ProteinsIBA 01/2020 - 01/2018
2	Glutathione (Reduced Glutathione)IBA 01/2020 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2009
2	Small Interfering RNA (siRNA)IBA 01/2019 - 09/2017
2	Peptides (Polypeptides)IBA 10/2017 - 06/2012
2	Protein Isoforms (Isoforms)IBA 09/2017 - 02/2010
2	Angiopoietin-2IBA 09/2017 - 11/2012
2	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2017 - 11/2012
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2017 - 11/2012
2	OligomycinsIBA 01/2017 - 11/2008
2	TerlipressinIBA 01/2016 - 05/2015
2	BilirubinIBA 01/2016 - 05/2015
2	Vasoconstrictor AgentsIBA 12/2015 - 01/2009
2	Vasodilator Agents (Vasodilators)IBA 12/2015 - 01/2009
2	SodiumIBA 05/2015 - 11/2005
2	p38 Mitogen-Activated Protein KinasesIBA 04/2014 - 04/2013
2	Pinacidil (Pindac)FDA Link 02/2014 - 06/2012
2	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 02/2014 - 11/2005
2	Adenosine (Adenocard)FDA LinkGeneric 05/2013 - 06/2012
2	Adenosine A1 ReceptorIBA 05/2013 - 06/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2012 - 11/2005
2	p21-Activated KinasesIBA 06/2011 - 01/2011
2	Myosin-Light-Chain KinaseIBA 06/2011 - 01/2008
1	Crystalloid SolutionsIBA 01/2022
1	Saline SolutionIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	LipidsIBA 01/2022
1	Sulfhydryl Compounds (Thiols)IBA 01/2022
1	Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA 11/2021
1	HexokinaseIBA 11/2021
1	18alpha,20beta- hydroxy- 11- oxo- norolean- 12- en- 3beta- yl- 2- O- beta- D- glucopyranurosyl- alpha- D- glucopyranosiduronate magnesium tetrahydrateIBA 08/2021
1	Alanine Transaminase (SGPT)IBA 08/2021
1	polyene phosphatidylcholineIBA 08/2021
1	Dexmedetomidine FDA Link 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 10/2020
1	fluorescein isothiocyanate bovine serum albuminIBA 01/2020
1	Cytochromes c (Cytochrome c)IBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 01/2020
1	AlbuminsIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2020
1	isothiocyanic acidIBA 01/2020
1	16S Ribosomal RNAIBA 01/2020
1	N(1)- (4- chlorobenzoyl)- N(2)- (1- (1- naphthyl)ethyl)- 1,2- diaminocyclohexaneIBA 01/2020

Therapy/Procedure

21	Resuscitation 01/2022 - 02/2002
10	Ligation 01/2021 - 05/2015
10	Punctures 01/2021 - 05/2015
2	Therapeutics 01/2021 - 01/2020